RARA CRAFT DATABASE for FDA Medical Devices
510(k)K190736

FDA DEVICE FACTS

Disposable Powder Free Nitrile Examination Glove,Blue Color, Tested For Use With Chemotherapy Drugs

Ever Growth (Vietnam) Co. , Ltd.

FDA-sourced product information for medical-device development research. Use the official FDA sources at the end of this page when the original public document wording is needed.医療機器開発の調査用に、FDA の公開情報から取った製品情報を示しています。公開文書の原文が必要なときは、このページの最後にある FDA の公式な出典をご覧ください。

DECISION DATEDecember 23, 2019PRODUCT CODELZA

Indications for use

A patient examination gloves is a disposable device intended for medical purpose that is worn on the examiner’s hand or fingers to prevent contamination between patient and examiner. In addition, these gloves were tested for use with chemotherapy drugs in accordance with ASTM D6978- 05 Standard Practice for Assessment of Medical gloves to Permeation by Chemotherapy Drugs: Table 5.1 Nitrile Blue color test for 36 chemotherapy drugs Test Chemotherapy Drug and Concentration Minimum Breakthrough Detection Time (Min.) 1 Bleomycin Sulfate 15.0 mg/ml > 240 2 Busulfan 6.0 mg/ml > 240 3 Carboplatin 10.0 mg/ml > 240 4 Carmustine (BCNU), 3.3 mg/ml 59.4 5 Chloroquine 50.0 mg/ml > 240 6 Cisplatin 1 mg/ml > 240 7 Cyclophosphamide 20 mg/ml > 240 8 Cyclosporin A 100.0 mg/ml > 240 9 Cytarabine 100.0 mg/ml > 240 10 Dacarbazine (DTIC), 10.0 mg/ml > 240 11 Daunorubicin 5.0 mg/ml > 240 12 Docetaxel 10.0 mg/m l > 240 13 Doxorubicin Hydrochloride, 2.0 mg/ml > 240 14 Epirubicin 2.0 mg/ml > 240 15 Etoposide (Toposar), 20.0 mg/ml > 240 1 Fludarabine 25.0 mg/ml > 240 17 Fluorouracil, 50.0 mg/ml > 240 18 Gemcitabine 38.0 mg/ml > 240 19 Idaribicin 1.0 mg/ml > 240 20 Ifosfamide 50.0 mg/ml > 240 21 Irinotecan 20.0 mg/ml > 240 22 Mechlorethamine H Cl 1.0 mg/ml > 240 23 Melphalan 5 mg/ml > 240 24 Methotrexate 25 mg/ml > 240 25 Mitomycin C 0.5 mg/ml > 240 26 Mitoxantrone 2.0 mg/ml > 240 27 Oxaliplatin 2.0 mg/m l > 240 28 Paclitaxel (Taxol), 6.0 mg/ml > 240 29 Paraplatin 10 mg/ml > 240 30 Retrovir 10 mg/ml > 240 31 Rituximab 10 mg/ml > 240 32 Thiotepa, 10.0 mg/ml 118.5 33 Topotecan HCl 1 mg/ml > 240 34 Trisonex 1 mg/ml > 240 35 Velcade (Bortezomib) 1 mg/m l > 240 36 Vincristine 1.0 mg/ml > 240 The maximum testing time is 240 minutes. Please note that the following drug has an extremely low permeation time: Carmustine (BCNU), 3.3 mg/ml 59.4 minutes Thiotepa, 10.0 mg/ml 118.5 minutes

See the full product information製品情報をすべて見るには

Device description, AI/software, PCCP, evaluation and limitations are available with an account: seven days of full access after free registration, then with the paid plan.機器の説明、AI・ソフトウェア、PCCP、評価、制限事項は、アカウントでご覧いただけます。無料登録から 7 日間はすべて利用でき、その後は有料プランでご利用いただけます。

Start free 7-day access7日間無料で利用するLog inログイン

OFFICIAL FDA SOURCES

FDA Record and Public Document Status

Record and document link states are stored separately.FDA Record と公開文書のリンクの状態は、別々に記録しています。

Information reviewed:情報の確認日: August 24, 2026